Miralax and Pancreatitis relapsing - a phase IV clinical study of FDA data

Summary:

Pancreatitis relapsing is reported as a side effect among people who take Miralax (polyethylene glycol 3350), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Ventolin Hfa, and have Nausea.

The phase IV clinical study analyzes which people have Pancreatitis relapsing when taking Miralax. It is created by eHealthMe based on reports of 80,819 people who have side effects when taking Miralax from the FDA, and is updated regularly.

What is Miralax?

Miralax has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 81,754 Miralax users. Check the latest studies of Miralax.

What is Pancreatitis relapsing?

Pancreatitis relapsing is found to be associated with 171 drugs and 299 conditions by eHealthMe. Check the latest studies of Pancreatitis relapsing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

80,819 people reported to have side effects when taking Miralax.
Among them, 11 people (0.01%) have Pancreatitis relapsing.

Could Miralax cause Pancreatitis relapsing?

Among these 11 people:

How long have people been on Miralax when they have Pancreatitis relapsing? *

What is the gender of people who have Pancreatitis relapsing when taking Miralax? *

female: 90 %
male: 10 %

What is the age of people who have Pancreatitis relapsing when taking Miralax? *

What are other drugs people take besides Miralax? *

What are other side effects people have besides Pancreatitis relapsing? *

Abdominal Pain: 5 people, 45.45%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 5 people, 45.45%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 5 people, 45.45%
Lipase Increased: 5 people, 45.45%
Cough: 5 people, 45.45%
Concomitant Disease Aggravated (advanced due to some of accompanying): 5 people, 45.45%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 5 people, 45.45%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 45.45%
Fever: 5 people, 45.45%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 45.45%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 6 people, 54.55%
Abdominal Pain Upper: 5 people, 45.45%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 5 people, 45.45%
Bronchopulmonary Aspergillosis Allergic (allergic lung disorder caused by aspergillus fungi): 5 people, 45.45%
Cystic Fibrosis (disease of the secretary glands): 5 people, 45.45%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 5 people, 45.45%
Depression: 5 people, 45.45%
Rickets (softening of bones): 5 people, 45.45%
Hypersensitivity: 5 people, 45.45%
Stress And Anxiety: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Miralax and have Pancreatitis relapsing?

- Check whether Pancreatitis relapsing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Miralax:

Miralax (81,754 reports)

Browse all side effects of Miralax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pancreatitis relapsing:

Pancreatitis relapsing (171 drugs)

Browse all the conditions that are associated with Pancreatitis relapsing:

Pancreatitis relapsing (299 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Miralax) and Miralax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.